Aradigm discussed data from Phase 3 trials assessing the company’s inhaled form of ciprofloxacin, called Linhaliq (formerly known as Pulmaquin), with the U.S. Food and Drug Administration (FDA) to advance the drug’s development and obtain marketing ... Read more